tiprankstipranks
Trending News
More News >
Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market

Unicycive Therapeutics (UNCY) Income Statement

Compare
746 Followers

Unicycive Therapeutics Income Statement

Last quarter (Q3 2025), Unicycive Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Unicycive Therapeutics's net income was $-6.01M. See Unicycive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 675.00K$ 951.00K$ 0.00$ 0.00
Gross Profit
$ 0.00$ 675.00K$ 951.00K$ 0.00$ 0.00
Operating Expenses
$ 32.12M$ 21.45M$ 19.00M$ 8.98M$ 2.02M
Depreciation and Amortization
$ 428.00K$ 284.00K$ 161.00K$ 13.00K$ 2.02M
EBITDA
$ -36.23M$ -30.18M$ -17.89M$ -9.38M$ 0.00
Operating Income
$ -32.12M$ -20.77M$ -18.05M$ -8.98M$ -2.02M
Other Income/Expenses
$ -4.61M$ -9.77M$ -6.00K$ -1.04M$ -244.00K
Pretax Income
$ -36.73M$ -30.54M$ -18.06M$ -10.02M$ -2.26M
Net Income
$ -36.73M$ -30.54M$ -18.06M$ -10.02M$ -2.51M
Per Share Metrics
Basic EPS
$ -5.60$ -1.28$ -1.20$ -8.60$ -0.16
Diluted EPS
$ -5.60$ -1.28$ -1.20$ -8.60$ -0.16
Weighted Average Shares Outstanding
- 2.45M 1.51M 1.17M 1.52M
Weighted Average Shares Outstanding (Diluted)
- 2.45M 1.51M 1.17M 1.52M
Currency in USD

Unicycive Therapeutics Earnings and Revenue History